Glucose Challenge Test for Detecting Gestational Diabetes Mellitus: a Systematic Review
Overview
Affiliations
Background: The best strategy to identify women with gestational diabetes mellitus (GDM) is unclear.
Objectives: To perform a systematic review to calculate summary estimates of the sensitivity and specificity of the 50-g glucose challenge test for GDM.
Search Strategy: Systematic search of MEDLINE, EMBASE and Web of Science.
Selection Criteria: Articles that compared the 50-g glucose challenge test with the oral glucose tolerance test (OGTT, with a 75- or 100-g reference standard) before 32 weeks of gestation.
Data Collection And Analysis: Summary estimates of sensitivity and specificity, with 95% confidence intervals and summary receiver operating characteristic curves, were calculated using bivariate random-effects models. Two reviewers independently selected articles that compared the 50 g glucose challenge test to the oral glucose tolerance test (OGTT, 75 or 100 gram, reference standard) before 32 weeks of gestation.
Main Results: Twenty-six studies were included (13,564 women). Studies that included women with risk factors showed a pooled sensitivity of the 50-g glucose challenge test of 0.74 (95% CI 0.62-0.87), a pooled specificity of 0.77 (95% CI 0.66-0.89) (threshold value of 7.8 mmol/l), a derived positive likelihood ratio (LR) of 3.2 (95% CI 2.0-5.2) and a negative LR of 0.34 (95% CI 0.22-0.53). In studies with consecutive recruitment, the pooled sensitivity was 0.74 (95% CI 0.62-0.87) for a specificity of 0.85 (95% CI 0.80-0.91), with a derived positive LR of 4.9 (95% CI 3.5-7.0) and negative LR of 0.31 (95% CI 0.20-0.47). Increasing the threshold for disease (OGTT result) increased the sensitivity of the challenge test, and decreased the specificity.
Author's Conclusions: The 50-g glucose challenge test is acceptable to screen for GDM, but cannot replace the OGTT. Further possibilities of combining the 50-g glucose challenge test with other screening strategies should be explored.
Pardo E, Yagur Y, Gluska H, Cohen G, Kovo M, Biron-Shental T Arch Gynecol Obstet. 2024; 310(3):1593-1598.
PMID: 38987458 DOI: 10.1007/s00404-024-07612-0.
Metzger B, Kuang A, Lowe Jr W, Scholtens D, Lowe L, Dyer A Diabetes Res Clin Pract. 2023; 205:110952.
PMID: 37838153 PMC: 10842388. DOI: 10.1016/j.diabres.2023.110952.
Sezer H, Yazici D, Bulut Canbaz H, Gonenli M, Yerlikaya A, Ata B North Clin Istanb. 2022; 9(2):140-148.
PMID: 35582504 PMC: 9039644. DOI: 10.14744/nci.2021.80588.
A Clinical Update on Gestational Diabetes Mellitus.
Sweeting A, Wong J, Murphy H, Ross G Endocr Rev. 2022; 43(5):763-793.
PMID: 35041752 PMC: 9512153. DOI: 10.1210/endrev/bnac003.
Kdekian A, Sietzema M, Scherjon S, Lutgers H, van der Beek E J Clin Med. 2021; 10(5).
PMID: 33801180 PMC: 7957868. DOI: 10.3390/jcm10050976.